Literature DB >> 22204729

Diabetic stem-cell "mobilopathy".

John F DiPersio1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22204729     DOI： 10.1056/NEJMcibr1112347

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  31 in total

1.  Prospective study of mobilization kinetics up to 18 hours after late-afternoon dosing of plerixafor.

Authors:  Patricia A Shi; Lorraine K Miller; Luis M Isola
Journal:  Transfusion       Date:  2013-10-16       Impact factor: 3.157

2.  Is chronic kidney disease-mineral and bone disorder associated with the presence of endothelial progenitor cells with a calcifying phenotype?

Authors:  Giuseppe Cianciolo; Irene Capelli; Maria Cappuccilli; Anna Scrivo; Chiara Donadei; Antonio Marchetti; Paola Rucci; Gaetano La Manna
Journal:  Clin Kidney J       Date:  2017-02-15

3.  Mobilization of allogeneic peripheral blood stem cell donors with intravenous plerixafor mobilizes a unique graft.

Authors:  Mark A Schroeder; Michael P Rettig; Sandra Lopez; Stephanie Christ; Mark Fiala; William Eades; Fazia A Mir; Jin Shao; Kyle McFarland; Kathryn Trinkaus; William Shannon; Elena Deych; Jinsheng Yu; Ravi Vij; Keith Stockerl-Goldstein; Amanda F Cashen; Geoffrey L Uy; Camille N Abboud; Peter Westervelt; John F DiPersio
Journal:  Blood       Date:  2017-03-14       Impact factor: 22.113

4.  Adiponectin regulates bone marrow mesenchymal stem cell niche through a unique signal transduction pathway: an approach for treating bone disease in diabetes.

Authors:  Liming Yu; Qisheng Tu; Qianqian Han; Lan Zhang; Lei Sui; Leilei Zheng; Shu Meng; Yin Tang; Dongying Xuan; Jin Zhang; Dana Murray; Qingping Shen; Jessica Cheng; Sung-Hoon Kim; Lily Q Dong; Paloma Valverde; Xinming Cao; Jake Chen
Journal:  Stem Cells       Date:  2015-01       Impact factor: 6.277

Review 5.  Cardiovascular actions of GLP-1 and incretin-based pharmacotherapy.

Authors:  Angelo Avogaro; Saula Vigili de Kreutzenberg; Gian Paolo Fadini
Journal:  Curr Diab Rep       Date:  2014       Impact factor: 4.810

Review 6.  The pleiotropic cardiovascular effects of dipeptidyl peptidase-4 inhibitors.

Authors:  Angelo Avogaro; Gian Paolo Fadini
Journal:  Br J Clin Pharmacol       Date:  2018-06-03       Impact factor: 4.335

7.  Targeting VLA4 integrin and CXCR2 mobilizes serially repopulating hematopoietic stem cells.

Authors:  Darja Karpova; Michael P Rettig; Julie Ritchey; Daniel Cancilla; Stephanie Christ; Leah Gehrs; Ezhilarasi Chendamarai; Moses O Evbuomwan; Matthew Holt; Jingzhu Zhang; Grazia Abou-Ezzi; Hamza Celik; Eliza Wiercinska; Wei Yang; Feng Gao; Linda G Eissenberg; Richard F Heier; Stacy D Arnett; Marvin J Meyers; Michael J Prinsen; David W Griggs; Andreas Trumpp; Peter G Ruminski; Dwight M Morrow; Halvard B Bonig; Daniel C Link; John F DiPersio
Journal:  J Clin Invest       Date:  2019-05-14       Impact factor: 14.808

8.  De-novo collateral formation following acute myocardial infarction: Dependence on CCR2⁺ bone marrow cells.

Authors:  Hua Zhang; James E Faber
Journal:  J Mol Cell Cardiol       Date:  2015-08-04       Impact factor: 5.000

9.  Efficacy of CD34+ Stem Cell Therapy in Nonischemic Dilated Cardiomyopathy Is Absent in Patients With Diabetes but Preserved in Patients With Insulin Resistance.

Authors:  Bojan Vrtovec; Matjaz Sever; Mojca Jensterle; Gregor Poglajen; Andrej Janez; Nika Kravos; Gregor Zemljic; Marko Cukjati; Peter Cernelc; François Haddad; Joseph C Wu; Ulrich P Jorde
Journal:  Stem Cells Transl Med       Date:  2016-03-29       Impact factor: 6.940

Review 10.  Concise review: diabetes, the bone marrow niche, and impaired vascular regeneration.

Authors:  Gian Paolo Fadini; Francesca Ferraro; Federico Quaini; Takayuki Asahara; Paolo Madeddu
Journal:  Stem Cells Transl Med       Date:  2014-06-18       Impact factor: 6.940
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.